Evaluation of Peripheral Retinal Leakage by Ultra-Widefield Fluorescein Angiography in Patients with Non proliferative Diabetic Retinopathy
European Journal of Clinical Pharmacy · 24.12.2025 · 7 (1) · 5976-5980
DOI: 10.61336/ejcp/25-01-687 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Pharmacy, online erschienen am 24.12.2025.
Abstract (Originalsprache)
Nonproliferative diabetic retinopathy (NPDR) is characterised by progressive microvascular damage that may extend beyond the posterior pole, where conventional imaging often fails to detect early peripheral ischemia and leakage.
Objective
To evaluate peripheral retinal leakage using ultra-widefield fluorescein angiography and determine its association with clinical severity, angiographic abnormalities, and treatment outcomes in patients with NPDR. Methodology: This was a hospital-based cross-sectional analytical study conducted at Bakhtawar Amin Hospital, Multan from August 2024 to August 2025 including 355 patients diagnosed with nonproliferative diabetic retinopathy (NPDR).
Results
Peripheral retinal leakage was detected in 213 patients (60%). The leakage group was older (58.4 ± 9.8 vs 55.9 ± 10.2 years, p = 0.032) and had longer diabetes duration (12.6 ± 5.1 vs 9.2 ± 4.7 years, p = 0.001). Moderate-to-severe NPDR was more frequent among patients with leakage (74.2% vs 38.7%, p = 0.001), along with higher rates of diabetic macular edema (50.2% vs 14.8%). Angiographic abnormalities were significantly greater in the leakage group, including capillary nonperfusion (78.4% vs 21.8%), peripheral ischemic index >10% (69.9% vs 12.7%), microaneurysm clusters (86.4% vs 42.3%), and vascular staining (51.2% vs 14.1%) (all p = 0.001). These patients also required more frequent laser therapy (43.2% vs 13.4%) and anti-VEGF treatment (41.3% vs 12.0%), with a lower rate of visual improvement at follow-up (63.8% vs 81.0%).
Conclusion
Peripheral retinal leakage is common in NPDR and is strongly associated with greater ischemic burden, higher disease severity, increased treatment requirements, and poorer visual outcomes. Ultra-widefield fluorescein angiography provides valuable additional information for comprehensive evaluation and risk stratification in patients with diabetic retinopathy
Zitieren
APA
(2025). Evaluation of Peripheral Retinal Leakage by Ultra-Widefield Fluorescein Angiography in Patients with Non proliferative Diabetic Retinopathy. European Journal of Clinical Pharmacy, 7(1), 5976-5980. https://doi.org/10.61336/ejcp/25-01-687
Vancouver
Evaluation of Peripheral Retinal Leakage by Ultra-Widefield Fluorescein Angiography in Patients with Non proliferative Diabetic Retinopathy. European Journal of Clinical Pharmacy. 2025;7(1):5976-5980. doi:10.61336/ejcp/25-01-687
BibTeX
@article{euvimed2025,
title = {Evaluation of Peripheral Retinal Leakage by Ultra-Widefield Fluorescein Angiography in Patients with Non proliferative Diabetic Retinopathy},
journal = {European Journal of Clinical Pharmacy},
year = {2025},
volume = {7},
number = {1},
pages = {5976--5980},
doi = {10.61336/ejcp/25-01-687}
}
EUVIMED